These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4343255)

  • 1. Corticosteroids in management of severe, generalized myasthenia gravis. Effectiveness and comparison with corticotropin therapy.
    Brunner NG; Namba T; Grob D
    Neurology; 1972 Jun; 22(6):603-10. PubMed ID: 4343255
    [No Abstract]   [Full Text] [Related]  

  • 2. The diagnosis and management of myasthenia gravis.
    Walsh JC
    Med J Aust; 1974 Jun; 1(25):997-1001. PubMed ID: 4369281
    [No Abstract]   [Full Text] [Related]  

  • 3. Corticotropin and corticosteroids in generalized myasthenia gravis: comparative studies and role in management.
    Brunner NG; Berger CL; Namba T; Grob D
    Ann N Y Acad Sci; 1976; 274():577-95. PubMed ID: 183590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin therapy in patients with myasthenia gravis. Electrophysiologic, pharmacologic studies.
    Namba T
    Arch Neurol; 1972 Feb; 26(2):144-50. PubMed ID: 4332732
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug therapy in myasthenia gravis].
    Aarli JA
    Tidsskr Nor Laegeforen; 1976 Dec; 96(34-36):1803-5. PubMed ID: 189451
    [No Abstract]   [Full Text] [Related]  

  • 6. Corticotropin therapy in myasthenia gravis: effects, indications, and limitations.
    Namba T; Brunner NG; Shapiro MS; Grob D
    Neurology; 1971 Oct; 21(10):1008-18. PubMed ID: 4329627
    [No Abstract]   [Full Text] [Related]  

  • 7. Symposium on therapeutic controversies. Myasthenia gravis. Steroids and immunosuppressive drugs.
    Johns TR; Howard FM
    Trans Am Neurol Assoc; 1978; 103():278-81. PubMed ID: 229611
    [No Abstract]   [Full Text] [Related]  

  • 8. High-dose intravenous methylprednisolone in myasthenia gravis.
    Arsura E; Brunner NG; Namba T; Grob D
    Arch Neurol; 1985 Dec; 42(12):1149-53. PubMed ID: 4062612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theophylline preparations in the treatment of myasthenia gravis.
    Jacobs R; Brumlik J; Karczmar AG
    Trans Am Neurol Assoc; 1971; 96():158-61. PubMed ID: 4333996
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunosuppressive treatment for juvenile myasthenia gravis.
    Badurska B; Ryniewicz B; Strugalska H
    Eur J Pediatr; 1992 Mar; 151(3):215-7. PubMed ID: 1601015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical and surgical treatment for ocular myasthenia.
    Benatar M; Kaminski H
    Cochrane Database Syst Rev; 2006 Apr; (2):CD005081. PubMed ID: 16625623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of myasthenia gravis pseudoparalytica. Analysis of 60 personal cases and study of the literature].
    Mumenthaler M; Ltschg J; Rossi L
    Clin Ter; 1976 Sep; 78(5):405-20. PubMed ID: 188592
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of myasthenia gravis in pregnancy].
    Pezzoli G; Bonfadini Bossi E; Rella R
    Minerva Ginecol; 1980; 32(1-2):21-6. PubMed ID: 6245392
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the treatment of myasthenia].
    Delwaide JP
    Rev Med Liege; 1968 Sep; 23(18):552-7. PubMed ID: 4316587
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of myasthenia gravis.
    Lancet; 1972 Apr; 1(7754):780-1. PubMed ID: 4111252
    [No Abstract]   [Full Text] [Related]  

  • 16. Maintenance adrenocorticotropic hormone (ACTH) treatment in myasthenia gravis.
    Cape CA; Utterback RA
    Neurology; 1972 Nov; 22(11):1160-4. PubMed ID: 4343649
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immuno suppressive drugs in the treatment of myasthenia (author's transl)].
    Buscaino GA
    Riv Patol Nerv Ment; 1974 Aug; 95(4):399-410. PubMed ID: 4377801
    [No Abstract]   [Full Text] [Related]  

  • 18. Corticotropin in generalized myasthenia gravis. Effect of short, intensive courses.
    Grob D; Namba T
    JAMA; 1966 Nov; 198(7):703-7. PubMed ID: 4288482
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of ACTH and corticosteroids in myasthenia gravis.
    Genkins G; Kornfeld P; Osserman KE; Namba T; Grob D; Brunner NG
    Ann N Y Acad Sci; 1971 Sep; 183():369-74. PubMed ID: 4330763
    [No Abstract]   [Full Text] [Related]  

  • 20. [Principles and limits of ACTH-cortisone therapy in neurology].
    Bammer HG
    Bibl Psychiatr Neurol; 1969; 139():36-59. PubMed ID: 4332888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.